Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185133 · ClinicalTrials.gov registry record · Phase 3
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
A Phase 3 study, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,900
- Enrollment target
NCT00185133: Completed Phase 3 study, sponsored by Daiichi Sankyo.
NCT00185133 is a Phase 3 study that has completed, run by Daiichi Sankyo. The registered enrollment target is 1,900 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (146% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185133, a Phase 3 study, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,900 participants
- Enrollment target
Study Summary
This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
Interventions
- DRUG Amlodipine
- DRUG Olmesartan medoxomil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,900 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
What the finished NCT00185133 record still lists
NCT00185133 is an interventional study that assigns participants to a tested intervention. Its 1,900 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (146% higher).
The record links to 0 conditions, and to 2 interventions - of which Amlodipine is the first listed.
NCT00185133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00185133 about?
NCT00185133 is a clinical study titled "Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension". This study assesses the efficacy and safety of co-administration of olmesartan medoxomil plus amlodipine in mild to severe hypertensive patients older than 18 years of age
What is the current status of trial NCT00185133?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,900 participants. The study started on 2005-05. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00185133?
The interventions under investigation include: Amlodipine (DRUG), Olmesartan medoxomil (DRUG).
Who is sponsoring clinical trial NCT00185133?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00185133's enrollment target sits among peer trials
1,900 110th of 2000 higher than 1,888 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- NCT07228234 · 1,900 participants · NA
Evaluating Mammography Communication Approaches
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia